JAK3 inhibitors have become a buzzword in pharmaceuticals, with significant implications for treating various diseases, including autoimmune disorders and cancers. JAK (Janus Kinase) inhibitors ...

Immune checkpoint inhibitors have changed the future of cancer care. These powerful treatments use the body’s own immune ...

Janus kinase (JAK) inhibitors are associated with decreased mortality and fewer serious adverse events among adults hospitalized with COVID-19.

In this article, learn about the dosage, uses, and ongoing research underway for JAK inhibitors available in the United States, as well as common side effects, contraindications, and warnings.

Discover a study uncovering how JAK inhibitors protect against autoimmune diabetes triggered by cancer immunotherapy.

SAN DIEGO — Janus kinase and interleukin-6 inhibitors are superior to other targeted agents as a first-line therapy for VEXAS syndrome, according to data presented at ACR Convergence 2023.&ldquo ...

JAK inhibitors can trigger a drop in your platelet, red blood cell, and white blood cell counts. Higher cholesterol. Your cholesterol may also rise while taking this medication in pill form.

If you have rheumatoid arthritis (RA), your doctor may suggest Janus kinase (JAK) inhibitors to help ease your joint pain and swelling. Find out how they work, who might benefit from them, and ...

Researchers compared four common JAK inhibitors, a medication used to treat rheumatoid arthritis (RA). The findings showed no significant differences in efficacy or safety between the four ...

Different Janus kinase (JAK) inhibitors underwent an evaluation for severe alopecia areata (AA) and found deuruxolitinib higher doses (12 mg) and baricitinib (4 mg) showed promise in hair regrowth ...

At 3 months, JAK inhibitors reduced pain scores by 4.0 mm (95% CI, 1.7-6.3) more than TNF inhibitors and by 3.9 mm (95% CI, 0.9-6.9) more than rituximab; however, the change in pain was not ...